These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 28333330)

  • 1. Genomic landscape of extended-spectrum β-lactamase resistance in Escherichia coli from an urban African setting.
    Musicha P; Feasey NA; Cain AK; Kallonen T; Chaguza C; Peno C; Khonga M; Thompson S; Gray KJ; Mather AE; Heyderman RS; Everett DB; Thomson NR; Msefula CL
    J Antimicrob Chemother; 2017 Jun; 72(6):1602-1609. PubMed ID: 28333330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High prevalence of ST131 among CTX-M-producing Escherichia coli from community-acquired infections, in the Czech Republic.
    Papagiannitsis CC; Študentová V; Jakubů V; Španělová P; Urbášková P; Žemličková H; Hrabák J
    Microb Drug Resist; 2015 Feb; 21(1):74-84. PubMed ID: 25188031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical epidemiology and molecular analysis of extended-spectrum-β-lactamase-producing Escherichia coli in Nepal: characteristics of sequence types 131 and 648.
    Sherchan JB; Hayakawa K; Miyoshi-Akiyama T; Ohmagari N; Kirikae T; Nagamatsu M; Tojo M; Ohara H; Sherchand JB; Tandukar S
    Antimicrob Agents Chemother; 2015; 59(6):3424-32. PubMed ID: 25824221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IncI1 plasmids carrying bla(CTX-M-1) or bla(CMY-2) genes in Escherichia coli from healthy humans and animals in Tunisia.
    Ben Sallem R; Ben Slama K; Rojo-Bezares B; Porres-Osante N; Jouini A; Klibi N; Boudabous A; Sáenz Y; Torres C
    Microb Drug Resist; 2014 Oct; 20(5):495-500. PubMed ID: 24826863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
    Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
    J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Genomic Analysis of Globally Dominant ST131 Clone with Other Epidemiologically Successful Extraintestinal Pathogenic
    Shaik S; Ranjan A; Tiwari SK; Hussain A; Nandanwar N; Kumar N; Jadhav S; Semmler T; Baddam R; Islam MA; Alam M; Wieler LH; Watanabe H; Ahmed N
    mBio; 2017 Oct; 8(5):. PubMed ID: 29066550
    [No Abstract]   [Full Text] [Related]  

  • 7. Wild Birds, Frequent Carriers of Extended-Spectrum β-Lactamase (ESBL) Producing Escherichia coli of CTX-M and SHV-12 Types.
    Alcalá L; Alonso CA; Simón C; González-Esteban C; Orós J; Rezusta A; Ortega C; Torres C
    Microb Ecol; 2016 Nov; 72(4):861-869. PubMed ID: 26687342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of CTX-M extended-spectrum beta-lactamases and sequence type 131 in Korean blood, urine, and rectal Escherichia coli isolates.
    Graham SE; Zhang L; Ali I; Cho YK; Ismail MD; Carlson HA; Foxman B
    Infect Genet Evol; 2016 Jul; 41():292-295. PubMed ID: 27101781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and characterization of multidrug-resistant and extended-spectrum beta-lactamase-producing Escherichia coli from pediatric wards of a Malaysian hospital.
    Ho WS; Balan G; Puthucheary S; Kong BH; Lim KT; Tan LK; Koh XP; Yeo CC; Thong KL
    Microb Drug Resist; 2012 Aug; 18(4):408-16. PubMed ID: 22394084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug susceptibility and molecular epidemiology of Escherichia coli in bloodstream infections in Shanghai, China, 2011-2013.
    Zhao SY; Wang YC; Xiao SZ; Jiang XF; Guo XK; Ni YX; Han LZ
    Infect Dis (Lond); 2015 May; 47(5):310-8. PubMed ID: 25712794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and characterization of extended-spectrum β-lactamase- and AmpC β-lactamase-producing Escherichia coli: results of the CANWARD 2007-2009 study.
    Simner PJ; Zhanel GG; Pitout J; Tailor F; McCracken M; Mulvey MR; Lagacé-Wiens PR; Adam HJ; Hoban DJ;
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):326-34. PubMed ID: 21353961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTX-M-15-D-ST648 Escherichia coli from companion animals and horses: another pandemic clone combining multiresistance and extraintestinal virulence?
    Ewers C; Bethe A; Stamm I; Grobbel M; Kopp PA; Guerra B; Stubbe M; Doi Y; Zong Z; Kola A; Schaufler K; Semmler T; Fruth A; Wieler LH; Guenther S
    J Antimicrob Chemother; 2014 May; 69(5):1224-30. PubMed ID: 24398338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole genome sequencing reveals high clonal diversity of
    Sonda T; Kumburu H; van Zwetselaar M; Alifrangis M; Mmbaga BT; Aarestrup FM; Kibiki G; Lund O
    Antimicrob Resist Infect Control; 2018; 7():72. PubMed ID: 29977533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Genomics of
    Ranjan A; Shaik S; Nandanwar N; Hussain A; Tiwari SK; Semmler T; Jadhav S; Wieler LH; Alam M; Colwell RR; Ahmed N
    mBio; 2017 Aug; 8(4):. PubMed ID: 28811343
    [No Abstract]   [Full Text] [Related]  

  • 15. Genomic epidemiology of
    Tegha G; Ciccone EJ; Krysiak R; Kaphatika J; Chikaonda T; Ndhlovu I; van Duin D; Hoffman I; Juliano JJ; Wang J
    Microb Genom; 2021 Jan; 7(1):. PubMed ID: 33295867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial Resistance and Molecular Epidemiology of Escherichia coli Causing Bloodstream Infections in Three Hospitals in Shanghai, China.
    Wang S; Zhao SY; Xiao SZ; Gu FF; Liu QZ; Tang J; Guo XK; Ni YX; Han LZ
    PLoS One; 2016; 11(1):e0147740. PubMed ID: 26824702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-genome sequences of multidrug-resistant Escherichia coli in South-Kivu Province, Democratic Republic of Congo: characterization of phylogenomic changes, virulence and resistance genes.
    Irenge LM; Ambroise J; Bearzatto B; Durant JF; Chirimwami RB; Gala JL
    BMC Infect Dis; 2019 Feb; 19(1):137. PubMed ID: 30744567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterisation of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli isolates from hospital and ambulatory patients in Germany.
    Pietsch M; Eller C; Wendt C; Holfelder M; Falgenhauer L; Fruth A; Grössl T; Leistner R; Valenza G; Werner G; Pfeifer Y;
    Vet Microbiol; 2017 Feb; 200():130-137. PubMed ID: 26654217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain.
    Blanco J; Mora A; Mamani R; López C; Blanco M; Dahbi G; Herrera A; Blanco JE; Alonso MP; García-Garrote F; Chaves F; Orellana MÁ; Martínez-Martínez L; Calvo J; Prats G; Larrosa MN; González-López JJ; López-Cerero L; Rodríguez-Baño J; Pascual A
    J Antimicrob Chemother; 2011 Sep; 66(9):2011-21. PubMed ID: 21669946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of infections caused by extended-spectrum β-lactamase-producing Escherichia coli from community hospitals in South Africa.
    Peirano G; van Greune CH; Pitout JD
    Diagn Microbiol Infect Dis; 2011 Apr; 69(4):449-53. PubMed ID: 21396544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.